These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26882020)

  • 1. DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging.
    Porto I; Vergallo R; Sangiorgi GM; Burzotta F; Garbo R; D'Amario D; Trani C; Rebuzzi AG; Crea F
    Coron Artery Dis; 2016 Jun; 27(4):334-6. PubMed ID: 26882020
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
    Abizaid A; Costa RA; Schofer J; Ormiston J; Maeng M; Witzenbichler B; Botelho RV; Costa JR; Chamié D; Abizaid AS; Castro JP; Morrison L; Toyloy S; Bhat V; Yan J; Verheye S
    JACC Cardiovasc Interv; 2016 Mar; 9(6):565-74. PubMed ID: 27013155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.
    Boeder NF; Dörr O; Bauer T; Elsässer A; Möllmann H; Achenbach S; Hamm CW; Nef HM
    Cardiovasc Revasc Med; 2019 Jun; 20(6):480-484. PubMed ID: 30638889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of side-branch jailing and a malapposed platinum marker after resorption of an everolimus-eluting bioresorbable vascular scaffold: serial optical coherence tomography observations.
    Karanasos A; Garcia-Garcia HM; van Geuns RJ; Regar E
    JACC Cardiovasc Interv; 2015 Mar; 8(3):e53-e54. PubMed ID: 25790767
    [No Abstract]   [Full Text] [Related]  

  • 5. Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.
    Braun D; Baquet M; Massberg S; Mehilli J; Hausleiter J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):e13-e14. PubMed ID: 26685077
    [No Abstract]   [Full Text] [Related]  

  • 6. Recanalized thrombus treated with bioresorbable vascular scaffold: insights from optical coherence tomography.
    Gómez-Monterrosas O; Regueiro A; Santos A; Otsuki S; Scalone G; Fernández-Rodríguez D; Sabaté M
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1453-5. PubMed ID: 25457058
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial intravascular ultrasound evaluation of the DESolve™ novolimus-eluting bioresorbable coronary scaffold system.
    Barreira G; Costa JR; Costa R; Staico R; Chamie D; Slhessarenko JR; Tanajura LF; Abizaid A; Sousa A; Abizaid A
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):E368-E374. PubMed ID: 29521477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions.
    Maeremans J; Verhaert D; Pereira B; Frambach P; Van Mieghem C; Barbato E; Willems E; Vrolix M; Dens J
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):488-496. PubMed ID: 29068171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter post-marketing evaluation of the Elixir DESolve
    Nef H; Wiebe J; Boeder N; Dörr O; Bauer T; Hauptmann KE; Latib A; Colombo A; Fischer D; Rudolph T; Foin N; Richardt G; Hamm C
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1021-1027. PubMed ID: 29508518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
    Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
    Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
    Sherbet DP; Christopoulos G; Karatasakis A; Danek BA; Kotsia A; Navara R; Michael TT; Roesle M; Rangan BV; Haagen D; Garcia S; Maniu C; Pershad A; Abdullah SM; Hastings JL; Kumbhani DJ; Luna M; Addo T; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2016; 17(7):444-449. PubMed ID: 27133499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus- Versus Novolimus-Eluting Bioresorbable Scaffolds for the Treatment of Coronary Artery Disease: A Matched Comparison.
    Wiebe J; Dörr O; Ilstad H; Husser O; Liebetrau C; Boeder N; Bauer T; Möllmann H; Kastrati A; Hamm CW; Nef HM
    JACC Cardiovasc Interv; 2017 Mar; 10(5):477-485. PubMed ID: 28216214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial assessment of bioresorbable-polymer sirolimus-eluting stent by coronary angioscopy and optical coherence tomography.
    Nakamura S; Kimura S; Nakagama S; Hayashi Y; Yamamoto T; Utsugi Y; Doi J; Mizusawa M; Araki M; Sudo Y; Hishikari K; Hikita H; Takahashi A; Isobe M
    Coron Artery Dis; 2017 Sep; 28(6):530-531. PubMed ID: 28402989
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
    Gori T; Schulz E; Hink U; Kress M; Weiers N; Weissner M; Jabs A; Wenzel P; Capodanno D; Münzel T
    JACC Cardiovasc Interv; 2015 May; 8(6):770-777. PubMed ID: 25999097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery.
    Wu Y; Shen L; Ge L; Wang Q; Qian J; Zhang F; Yao K; Huang D; Chen Y; Ge J
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():630-7. PubMed ID: 26864162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging Comparison of a Bioresorbable Vascular Scaffold by High-Frequency Intravascular Ultrasound and Optical Coherence Tomography.
    Shan P; Motivala A; Moses J; Maehara A; Mintz GS; Ali ZA
    JACC Cardiovasc Interv; 2015 Sep; 8(11):e187-e188. PubMed ID: 26404210
    [No Abstract]   [Full Text] [Related]  

  • 19. Side branch occlusion after bioresorbable vascular scaffold implantation: lessons from optimal coherence tomography.
    Sato K; Panoulas VF; Kawamoto H; Naganuma T; Miyazaki T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):116-8. PubMed ID: 25616826
    [No Abstract]   [Full Text] [Related]  

  • 20. An Unusual Complication After Bioresorbable Scaffold Implantation: Visualization of Intramural Hematoma by Optical Coherence Tomography.
    Zhang BC; Karanasos A; Royaards KJ; Ligthart J; Regar E
    JACC Cardiovasc Interv; 2015 Aug; 8(9):e143-e145. PubMed ID: 26292606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.